{
  "title": "Effects of radical surgery, chemotherapy combined with PD-1 inhibitor camrelizumab on prognosis of hilar cholangiocarcinoma patients and its clinical significance.",
  "pmid": "40761045",
  "doi": null,
  "affiliations": [
    "Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China/Institute of Hepato-Biliary-Pancreatic-Intestinal Disease, North Sichuan Medical College, Nanchong, China.",
    "Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China/Institute of Hepato-Biliary-Pancreatic-Intestinal Disease, North Sichuan Medical College, Nanchong, China.",
    "Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China/Institute of Hepato-Biliary-Pancreatic-Intestinal Disease, North Sichuan Medical College, Nanchong, China.",
    "Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China/Institute of Hepato-Biliary-Pancreatic-Intestinal Disease, North Sichuan Medical College, Nanchong, China.",
    "Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China/Institute of Hepato-Biliary-Pancreatic-Intestinal Disease, North Sichuan Medical College, Nanchong, China."
  ]
}